NO801775L - Fremgangsmaate ved fremstilling av hypocholesteremiske forbindelser - Google Patents

Fremgangsmaate ved fremstilling av hypocholesteremiske forbindelser

Info

Publication number
NO801775L
NO801775L NO801775A NO801775A NO801775L NO 801775 L NO801775 L NO 801775L NO 801775 A NO801775 A NO 801775A NO 801775 A NO801775 A NO 801775A NO 801775 L NO801775 L NO 801775L
Authority
NO
Norway
Prior art keywords
hypocholesteremic
compounds
procedure
preparation
hypocholesteremic compounds
Prior art date
Application number
NO801775A
Other languages
English (en)
Other versions
NO155699C (no
NO155699B (no
Inventor
Richard L Monaghan
Alfred W Alberts
Carl H Hoffman
George Albers-Schonberg
Henry Joshua
Maria B Lopez
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27367450&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO801775(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/048,946 external-priority patent/US4231938A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO801775L publication Critical patent/NO801775L/no
Publication of NO155699B publication Critical patent/NO155699B/no
Publication of NO155699C publication Critical patent/NO155699C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/66Aspergillus
NO801775A 1979-06-15 1980-06-13 Fremgangsmaate ved fremstilling av hypocholesteremiske forbindelser. NO155699C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/048,946 US4231938A (en) 1979-06-15 1979-06-15 Hypocholesteremic fermentation products and process of preparation
US7780779A 1979-09-21 1979-09-21
US11445980A 1980-01-23 1980-01-23

Publications (3)

Publication Number Publication Date
NO801775L true NO801775L (no) 1980-12-16
NO155699B NO155699B (no) 1987-02-02
NO155699C NO155699C (no) 1987-05-13

Family

ID=27367450

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801775A NO155699C (no) 1979-06-15 1980-06-13 Fremgangsmaate ved fremstilling av hypocholesteremiske forbindelser.

Country Status (20)

Country Link
EP (1) EP0022478B1 (no)
AR (1) AR224008A1 (no)
AT (1) ATE2620T1 (no)
AU (1) AU535944B2 (no)
CA (1) CA1161380A (no)
DD (1) DD157344A5 (no)
DE (1) DE3062122D1 (no)
DK (1) DK149003C (no)
EG (1) EG16957A (no)
ES (1) ES492384A0 (no)
FI (1) FI67231C (no)
GR (1) GR69216B (no)
IE (1) IE49685B1 (no)
IL (1) IL60219A (no)
NO (1) NO155699C (no)
NZ (1) NZ193922A (no)
PL (1) PL125843B1 (no)
PT (1) PT71371B (no)
RO (1) RO79487A (no)
ZW (1) ZW13480A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925599B2 (ja) * 1979-02-20 1984-06-19 三共株式会社 新生理活性物質モナコリンkおよびその製造法
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Mb−530a誘導体
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb−530b誘導体およびその製造法
DE8533814U1 (de) * 1985-11-30 1986-01-16 Beiersdorf Ag, 2000 Hamburg Vorrichtung zum Spülen des Darmes
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
DE3739882A1 (de) * 1987-11-25 1989-06-08 Bayer Ag Substituierte hydroxylamine
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
AU618158B2 (en) * 1989-01-07 1991-12-12 Bayer Aktiengesellschaft New substituted pyrido(2,3-d)pyrimidines
DE3911064A1 (de) * 1989-04-06 1990-10-11 Bayer Ag Substituierte 1,8-naphthyridine
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
NZ245713A (en) * 1992-02-10 1994-12-22 Novopharm Ltd Production of the antibiotic lovastatin from genetically engineered aspergillus strains
JPH07504568A (ja) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 HMG−CoAレダクターゼ阻害物質としてのテトラリン誘導体
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
DE4244029A1 (de) * 1992-12-24 1994-06-30 Bayer Ag Neue substituierte Pyridine
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
RU2158607C2 (ru) * 1995-07-03 2000-11-10 Санкио Компани Лимитед Лечение артериосклероза и ксантомы
CA2199104A1 (en) 1996-03-05 1997-09-05 Tsuneaki Hida Xanthene derivatives, their production and use
KR100576576B1 (ko) * 1997-02-20 2006-05-04 디에스엠 아이피 어셋츠 비.브이. 화학적 합성 배지를 이용하는 가치있는 화합물들의 산업적 규모의 발효적 생산
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
SI9800057A (sl) 1998-02-26 1999-08-31 Krka, Tovarna Zdravil, D.D. Postopek za pripravo simvastatina in njegovih derivatov
EP2359826B1 (en) 2006-07-05 2013-10-30 Takeda GmbH Combination of HMG-COA reductase inhibitor rosuvastatin with a phosphodiesterase 4 inhibitor, such as roflumilast, roflumilast-N-oxide for the treatment of inflammatory pulmonary diseases
EP2373609B1 (en) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049495A (en) * 1974-06-07 1977-09-20 Sankyo Company Limited Physiologically active substances and fermentative process for producing the same
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent

Also Published As

Publication number Publication date
DK149003B (da) 1985-12-16
PT71371A (en) 1980-07-01
ATE2620T1 (de) 1983-03-15
IE49685B1 (en) 1985-11-27
RO79487A (ro) 1982-07-06
EP0022478A1 (en) 1981-01-21
DK149003C (da) 1986-08-18
ES8105389A1 (es) 1981-06-01
DE3062122D1 (en) 1983-03-31
IL60219A0 (en) 1980-09-16
NO155699C (no) 1987-05-13
PL125843B1 (en) 1983-06-30
ZW13480A1 (en) 1982-02-03
NO155699B (no) 1987-02-02
AU535944B2 (en) 1984-04-12
EG16957A (en) 1990-06-30
FI67231C (fi) 1985-02-11
NZ193922A (en) 1982-05-25
FI67231B (fi) 1984-10-31
PL224920A1 (no) 1981-03-27
DK254180A (da) 1980-12-16
GR69216B (no) 1982-05-07
IE801232L (en) 1980-12-15
IL60219A (en) 1985-05-31
AU5901780A (en) 1980-12-18
AR224008A1 (es) 1981-10-15
FI801857A (fi) 1980-12-16
PT71371B (en) 1981-10-21
DD157344A5 (de) 1982-11-03
ES492384A0 (es) 1981-06-01
EP0022478B1 (en) 1983-02-23
CA1161380A (en) 1984-01-31

Similar Documents

Publication Publication Date Title
NO801775L (no) Fremgangsmaate ved fremstilling av hypocholesteremiske forbindelser
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
NO148281C (no) Fremgangsmaate ved fremstilling av allergenholdige forbindelser
NO781082L (no) Fremgangsmaate ved fremstilling av jodofore forbindelser
NO800030L (no) Fremgangsmaate ved fremstilling av 2-penem-forbindelser
NO813339L (no) R fremgangsmaate ved fremstilling av substituerte iminodisyre
NO153974C (no) Fremgangsmaate til fremstilling av forbindelsen monacolin k
NO792474L (no) Fremgangsmaate ved fremstilling av indanyl-derivater
NO773312L (no) Fremgangsmaate ved fremstilling av forbedrede zeolitter
NO802361L (no) Fremgangsmaate for fremstilling av titanforbindelser ved bruk av et reduseringsmiddel
NO781824L (no) Fremgangsmaate ved fremstilling av analgesisk aktive forbindelser
MX7633E (es) Procedimiento para la preparacion de compuestos de difenileter
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
ES488196A0 (es) Procedimiento para la preparacion de compuestos de dioxacinabasicos
NO802349L (no) Fremgangsmaate for fremstilling av titanforbindelser
NO801934L (no) Fremgangsmaate for fremstilling av ringklorerte alkylbenzener
NO803247L (no) R fremgangsmaate ved fremstilling av nye pyridothienotriazine
MX6580E (es) Procedimiento para la preparacion de compuestos acetoximetil-penam
NO820281L (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider
NO801157L (no) Fremgangsmaate ved fremstilling av amidholdige polymerer
NO813814L (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser
NO802834L (no) Fremgangsmaate ved fremstilling av 2-amino-3-benzoyl-fenylacetamider
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
DK69680A (da) Fremgangsmaade til fremstilling af diorganomagnesiumforbindelser